Friday, March 20, 2015 3:50:16 PM
DUKE BASKETBALL and NOTRE DAME FOOTBALL
Recent PRTA News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/13/2026 09:16:32 PM
- Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 • Business Wire • 02/12/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:26:08 PM
- Prothena Announces Board of Directors Update • Business Wire • 12/12/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 09:30:57 PM
- Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025 • Business Wire • 11/19/2025 09:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2025 12:47:09 AM
- Prothena Highlights Phase 2 Data for Coramitug (Formerly PRX004) Published in Circulation, Official Journal of AHA • Business Wire • 11/11/2025 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:28:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2025 09:18:26 PM
- Prothena Reports Third Quarter 2025 Financial Results and Business Highlights • Business Wire • 11/06/2025 09:05:00 PM
- Prothena to Report Third Quarter 2025 Financial Results on November 6 • Business Wire • 10/30/2025 08:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/17/2025 08:07:58 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/07/2025 08:31:45 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/07/2025 08:30:26 PM
- Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease • Business Wire • 10/01/2025 08:45:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/25/2025 08:30:36 PM
- Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference • Business Wire • 08/28/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:15:38 PM
- Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program • Business Wire • 08/27/2025 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/15/2025 12:17:57 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/14/2025 05:16:31 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2025 08:30:29 PM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
